Same biologic outcome. Smarter cost.
The same biologic outcomes your patients rely on — with verified quality, dependable supply and smarter cost options.
Trusted equivalence, meaningful savings
Biosimilars are rigorously evaluated, regulator-approved biologics — equivalent in efficacy and safety to the originator, at a cost that lets your formulary and your patients go further.
Value biologics across every class
39 verified biosimilars across the major biologic classes — immunology, oncology, supportive and specialty care, interchangeable where approved.
We support the whole switch
Moving from originator to biosimilar is a clinical and operational decision — we support both, end to end.
Confidence in every switch
What an accountable biosimilars partner delivers for your institution.
Quality you can switch to with confidence
Regulator-approved sourcing and resilient, cold-chain supply underpin every biosimilar we list.
Savings ranges and service levels shown are illustrative, agreed per institution in the supply agreement.
Widening access to the biologics that change lives
"Verified, interchangeable-where-approved biosimilars across immunology, oncology, supportive and specialty care."
Switch with confidence to value biologics
Talk to us about a biosimilars partnership that protects quality, supply and your formulary budget.